Regulatory Approval

Regulatory Approval

Eco Animal Health Group Plc

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a number of marketing authorisations for Aivlosin® from the Department for Food Safety and Veterinary from the State Service of Ukraine on Food Safety and Consumer Protection.

Aivlosin ^® , ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both pigs and poultry, also allow ECO to start selling Aivlosin® in the Ukraine for the medication of drinking water or for mixing into feed, for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

These new treatments meet all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, these treatments are under the control of veterinarians, available under prescription only and have low, highly effective therapeutic dose rates, a short treatment duration and a zero day or very short drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in the Ukraine, the sixteenth largest egg producing country and one that is ranked just outside the top twenty globally for pork production.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence	Â	020 8336 6190
Marc Loomes		020 8447 6906
Spiro Financial
Anthony Spiro		020 8336 6196
N+1 Singer (Nominated Adviser)		020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden		020 7418 8900
		Â

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20180121005079/en/